Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy
To evaluate the clinical response rate of neoadjuvant chemotherapy with gemcitabine and cisplatin in patients with operable NSCLC
Carcinoma, Non-Small-Cell Lung
DRUG: gemcitabine|DRUG: Cisplatin
Antitumor activity
Duration of response, time to progressive disease, time to treatment failure
To evaluate the clinical response rate of neoadjuvant chemotherapy with gemcitabine and cisplatin in patients with operable NSCLC